Correlation Between GlaxoSmithKline PLC and More Return

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both GlaxoSmithKline PLC and More Return at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining GlaxoSmithKline PLC and More Return into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between GlaxoSmithKline PLC ADR and More Return Public, you can compare the effects of market volatilities on GlaxoSmithKline PLC and More Return and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in GlaxoSmithKline PLC with a short position of More Return. Check out your portfolio center. Please also check ongoing floating volatility patterns of GlaxoSmithKline PLC and More Return.

Diversification Opportunities for GlaxoSmithKline PLC and More Return

0.21
  Correlation Coefficient

Modest diversification

The 3 months correlation between GlaxoSmithKline and More is 0.21. Overlapping area represents the amount of risk that can be diversified away by holding GlaxoSmithKline PLC ADR and More Return Public in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on More Return Public and GlaxoSmithKline PLC is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on GlaxoSmithKline PLC ADR are associated (or correlated) with More Return. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of More Return Public has no effect on the direction of GlaxoSmithKline PLC i.e., GlaxoSmithKline PLC and More Return go up and down completely randomly.

Pair Corralation between GlaxoSmithKline PLC and More Return

Considering the 90-day investment horizon GlaxoSmithKline PLC ADR is expected to generate 0.08 times more return on investment than More Return. However, GlaxoSmithKline PLC ADR is 12.02 times less risky than More Return. It trades about -0.3 of its potential returns per unit of risk. More Return Public is currently generating about -0.07 per unit of risk. If you would invest  3,745  in GlaxoSmithKline PLC ADR on August 28, 2024 and sell it today you would lose (330.00) from holding GlaxoSmithKline PLC ADR or give up 8.81% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

GlaxoSmithKline PLC ADR  vs.  More Return Public

 Performance 
       Timeline  
GlaxoSmithKline PLC ADR 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days GlaxoSmithKline PLC ADR has generated negative risk-adjusted returns adding no value to investors with long positions. Despite uncertain performance in the last few months, the Stock's basic indicators remain quite persistent which may send shares a bit higher in December 2024. The latest mess may also be a sign of long-standing up-swing for the company institutional investors.
More Return Public 

Risk-Adjusted Performance

9 of 100

 
Weak
 
Strong
OK
Compared to the overall equity markets, risk-adjusted returns on investments in More Return Public are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite quite weak forward-looking signals, More Return disclosed solid returns over the last few months and may actually be approaching a breakup point.

GlaxoSmithKline PLC and More Return Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with GlaxoSmithKline PLC and More Return

The main advantage of trading using opposite GlaxoSmithKline PLC and More Return positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if GlaxoSmithKline PLC position performs unexpectedly, More Return can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in More Return will offset losses from the drop in More Return's long position.
The idea behind GlaxoSmithKline PLC ADR and More Return Public pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the My Watchlist Analysis module to analyze my current watchlist and to refresh optimization strategy. Macroaxis watchlist is based on self-learning algorithm to remember stocks you like.

Other Complementary Tools

AI Portfolio Architect
Use AI to generate optimal portfolios and find profitable investment opportunities
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities
Premium Stories
Follow Macroaxis premium stories from verified contributors across different equity types, categories and coverage scope
Volatility Analysis
Get historical volatility and risk analysis based on latest market data
Content Syndication
Quickly integrate customizable finance content to your own investment portal